OGN vs USAR · P/E 3.4, rev $6.40B vs $5.72B cap
Organon & Co (OGN) versus USA Rare Earth, Inc. (USAR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
USA Rare Earth, Inc. (USAR) is a other industrial metals & mining company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
USAR does not have a complete income-statement cache yet.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. USAR currently screens at market cap $5.72B.
Not investment advice. Open the OGN and USAR stock pages for the full models.
Not investment advice.